Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 9,200 shares at $20.42 ($188K) on 2026-05-21, disclosed to the SEC on 2026-05-26.
Scheduled sale ($188k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |
| BCAX | SELL | 2026-03-05 | $602K | — | Filing → |